Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases

Clinical trial NCT04834089 · UNKNOWN

Trial details

NCT number: NCT04834089
Sponsor: Butantan Institute
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Immunosuppression Cancer COVID-19 Other Complication of Kidney Transplant Chemotherapy Renal Disease Diabetes Mellitus Cardiovascular Diseases Chronic Obstructive Pulmonary Disease

Start date: 2021-05-01
Primary completion: 2022-05-01
Enrollment: 618

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.